Tecan Group AG (LON:0QLN)

Market Cap	1.48B -34.2%
Revenue (ttm)	832.06M -9.3%
Net Income	57.94M -37.7%
EPS	4.54 -37.2%
Shares Out	n/a
PE Ratio	25.48
Forward PE	17.61
Dividend	2.79 (2.32%)
Ex-Dividend Date	Apr 14, 2025

Volume	2,300
Average Volume	28,510
Open	121.35
Previous Close	125.59
Day's Range	119.00 - 121.60
52-Week Range	119.00 - 191.10
Beta	1.25
RSI	33.13
Earnings Date	Mar 16, 2026

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized O...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1980
• Employees: 3,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QLN

Financial Performance

In 2024, Tecan Group AG's revenue was 934.28 million, a decrease of -13.04% compared to the previous year's 1.07 billion. Earnings were 67.66 million, a decrease of -48.77%.

Financial numbers in CHF